These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 19643561

  • 1. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Peng ZW, Chen MS, Liang HH, Gao HJ, Zhang YJ, Li JQ, Zhang YQ, Lau WY.
    Eur J Surg Oncol; 2010 Mar; 36(3):257-63. PubMed ID: 19643561
    [Abstract] [Full Text] [Related]

  • 2. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM, Wang JH, Zhen ZJ, Chen HW, Cui WZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [Abstract] [Full Text] [Related]

  • 3. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang Z, Wu M, Chen H, Chen D, He J.
    Zhonghua Wai Ke Za Zhi; 2002 Nov; 40(11):826-9. PubMed ID: 12487855
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF, Chan AO, Wong BC, Hui CK, Ooi GC, Tso WK, Yuan HJ, Wong DK, Lai CL.
    Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Peng ZW, Zhang YJ, Chen MS, Liang HH, Li JQ, Zhang YQ, Lau WY.
    Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
    [Abstract] [Full Text] [Related]

  • 8. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN.
    Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
    Lu W, Li Y, He X, Chen Y.
    Hepatogastroenterology; 2003 Mar; 50(54):2079-83. PubMed ID: 14696468
    [Abstract] [Full Text] [Related]

  • 11. [Percutaneous radiofrequency ablation combined with other minimally invasive treatments for recurrent hepatocellular carcinoma after hepatectomy].
    Xu L, Li P, Chen MS, Pang XH, Gao HJ, Peng ZW, Liang HH, Zhang YJ, Li JQ.
    Zhonghua Wai Ke Za Zhi; 2008 Nov 01; 46(21):1617-20. PubMed ID: 19094753
    [Abstract] [Full Text] [Related]

  • 12. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D, Sponza M, Marzio A, Zanardi R, Bazzocchi M, Cemal Y.
    Radiol Med; 2002 Nov 01; 104(5-6):412-20. PubMed ID: 12589262
    [Abstract] [Full Text] [Related]

  • 13. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma.
    Shim SJ, Seong J, Han KH, Chon CY, Suh CO, Lee JT.
    Liver Int; 2005 Dec 01; 25(6):1189-96. PubMed ID: 16343071
    [Abstract] [Full Text] [Related]

  • 14. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, Gu YK, Zhao M, Gao F, Jiao DC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 24; 89(11):754-7. PubMed ID: 19595104
    [Abstract] [Full Text] [Related]

  • 15. Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
    Takayasu K, Arii S, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Kokudo N, Makuuchi M.
    J Hepatol; 2012 Apr 24; 56(4):886-92. PubMed ID: 22173160
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.
    Am J Clin Oncol; 2003 Aug 24; 26(4):e92-9. PubMed ID: 12902905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.